Physician profile
Jooby John
NPI 1891897880
$9,771.55
in general payments reported to CMS, 2019-2025
31 companies · $1,059 in 2025
The $1,059 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $3,242 · 2021: $1,284 · 2022: $945 · 2023: $929 · 2024: $510 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,498.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,450.41 | 2019-2025 | Mitraclip, Navitor |
| Medtronic, INC. | $1,712.97 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Resolute Onyx |
| Penumbra, INC. | $1,399.46 | 2020-2025 | Indigo System |
| Abiomed | $999.85 | 2019-2025 | |
| Edwards Lifesciences Corporation | $273.28 | 2023-2024 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $271.08 | 2019-2022 | |
| Medtronic Vascular, INC. | $227.63 | 2019-2020 | |
| Teleflex LLC | $183.49 | 2025 | Manta |
| Inari Medical, INC. | $174.19 | 2020 | |
| Hitachi Healthcare Americas Corp. | $170.72 | 2020 | |
| Kestra Medical Technology Services, INC. | $161.00 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.41 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $106.64 | 2019-2021 | |
| Amgen INC. | $105.98 | 2021-2024 | Repatha |
| Cvrx, INC. | $40.99 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $39.35 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $37.90 | 2022-2023 | Verquvo |
| Kiniksa Pharmaceuticals, Ltd. | $37.52 | 2023 | Arcalyst |
| Biosense Webster, INC. | $35.48 | 2024 | Nuvision Ice Catheter |
| Acist Medical Systems, INC. | $35.23 | 2023 | |
| Esperion Therapeutics, INC. | $33.85 | 2021-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $27.63 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $26.66 | 2024 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $18.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.91 | 2023 | Jardiance |
| Pfizer INC. | $15.52 | 2023 | |
| Acutus Medical, INC. | $14.77 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.78 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.25 | 2021 | |
| Cardiovascular Systems INC. | $6.44 | 2019 | |
| Bardy Diagnostics, INC. | $6.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jooby John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.